SCHEMBL1306558

SCHEMBL1306558

COCCNC(=O)/C(=C/CCCCC(=O)OC)COc1cccc2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 2/20 0.47
▸ HPGD P15428 3/20 0.47
▸ KDM4E B2RXH2 3/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ CNR1 P21554 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.44
▸ OGG1 O15527 1/20 0.41
▸ TSHR P16473 2/20 0.40
▸ BTN3A1 O00481 1/20 0.40
▸ SLC6A4 P31645 2/20 0.40
▸ HRH1 P35367 1/20 0.40
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ HTR1B P28222 2/20 0.38
▸ HTR1D P28221 1/20 0.38
▸ NR2E1 Q9Y466 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1306561 1.00 CNR2 (0.47) CNR2HPGDKDM4EALDH1A1CNR1
SCHEMBL1308527 0.92 HPGD (0.49) CNR2HPGDKDM4EALDH1A1TDP1
SCHEMBL1308523 0.92 HPGD (0.49) CNR2HPGDKDM4EALDH1A1TDP1
SCHEMBL1305811 0.91 HPGD (0.45) HPGDKDM4EALDH1A1TDP1OGG1
SCHEMBL29488485 0.91 HPGD (0.45) HPGDKDM4EALDH1A1TDP1OGG1
SCHEMBL1305817 0.91 HPGD (0.45) HPGDKDM4EALDH1A1TDP1OGG1
SCHEMBL22403025 0.88 HTR1B (0.45) CNR2HPGDKDM4EALDH1A1CNR1
SCHEMBL12115952 0.87 CNR2 (0.48) CNR2HPGDKDM4EALDH1A1CNR1
SCHEMBL1306595 0.86 CNR2 (0.41) CNR2HPGDKDM4EALDH1A1CNR1
SCHEMBL1308955 0.86 CNR2 (0.41) CNR2HPGDKDM4EALDH1A1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8053435-B2 Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2011-11-08 — — US disclosed
Send feedback